Sign In
Buy PGEN
$6.27
+0.330 (+5.56%)
At Close: Jul 31, 2026
Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech
09:34am, Wednesday, 11'th Feb 2026
Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech
Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of “Hold” from Brokerages
04:44am, Tuesday, 10'th Feb 2026
Precigen, Inc. (NASDAQ: PGEN - Get Free Report) has been assigned an average rating of "Hold" from the seven brokerages that are covering the stock, MarketBeat reports. Two analysts have rated the sto
Independent, expert-led consensus paper, sponsored by the Recurrent Respiratory Papillomatosis Foundation, reflects the recommendation of 16 leading physicians in the field of RRP Consensus paper reco
Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
12:55pm, Thursday, 15'th Jan 2026
Precigen, Inc. (PGEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS in August 2025, the first-and-only FDA-approved treatment for adults with RRP PAPZIMEOS commercialization is well
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
04:05pm, Monday, 05'th Jan 2026
GERMANTOWN, Md., Jan. 5, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company advancing innovative precision medicines, today announced that Helen Sabzevari, PhD, President
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?
04:38pm, Tuesday, 02'nd Dec 2025
San Diego-based Tang Capital Management initiated new stake: up 12,400,000 shares, an estimated $40.8 million Change represents 1.6% of reportable assets under management Post-trade holding: 12,400,00
Precigen Is Still A Buy After The Papzimeos Rally
06:51am, Tuesday, 25'th Nov 2025
Precigen (PGEN) remains a Buy after PAPZIMEOS' FDA approval and launch, with higher-than-expected pricing and broad label supporting robust revenue potential. A new Pharmakon credit facility extends P
Precigen (NASDAQ:PGEN) Stock Price Up 28.9% on Analyst Upgrade
03:46am, Saturday, 15'th Nov 2025
Precigen, Inc. (NASDAQ: PGEN - Get Free Report) traded up 28.9% during trading on Friday after HC Wainwright raised their price target on the stock from $8.50 to $9.00. HC Wainwright currently has a b
Precigen Sees Unusually Large Options Volume (NASDAQ:PGEN)
02:19am, Saturday, 15'th Nov 2025
Precigen, Inc. (NASDAQ: PGEN - Get Free Report) was the recipient of unusually large options trading activity on Friday. Traders acquired 10,952 call options on the stock. This represents an increase
Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript
10:51pm, Thursday, 13'th Nov 2025
Precigen, Inc. ( PGEN ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Steven Harasym - VP & Head of Investor Relations Helen Sabzevari - President, CEO & Director Phil Tenna
Precigen Reports Third Quarter 2025 Financial Results and Business Updates
04:05pm, Thursday, 13'th Nov 2025
PAPZIMEOS (zopapogene imadenovec-drba) received full approval by the FDA in August PAPZIMEOS launched with a broad label in the US as the first and only FDA-approved treatment for adults with RRP PAPZ
Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
04:30pm, Thursday, 06'th Nov 2025
GERMANTOWN, Md. , Nov. 6, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of pa
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares
12:33pm, Saturday, 01'st Nov 2025
Patient Capital increased its holding by 10.2 million shares, an estimated $28.78 million trade based on the average price for the quarter Transaction value represents 1.15% of reported 13F assets und
15 out of 18 complete responders (83%) demonstrate continued complete response with median follow-up of 36 months Reduction in surgeries compared to year prior to treatment with PAPZIMEOS was observed
